Expanding the spectrum of neuronal pathology in multiple system atrophy

Matthew D. Cykowski, Elizabeth Coon, Suzanne Z. Powell, Sarah M. Jenkins, Eduardo E. Benarroch, Phillip Anson Low, Ann M. Schmeichel, Joseph E Parisi

Research output: Contribution to journalArticle

83 Citations (Scopus)

Abstract

Multiple system atrophy is a sporadic alpha-synucleinopathy that typically affects patients in their sixth decade of life and beyond. The defining clinical features of the disease include progressive autonomic failure, parkinsonism, and cerebellar ataxia leading to significant disability. Pathologically, multiple system atrophy is characterized by glial cytoplasmic inclusions containing filamentous alpha-synuclein. Neuronal inclusions also have been reported but remain less well defined. This study aimed to further define the spectrum of neuronal pathology in 35 patients with multiple system atrophy (20 male, 15 female; mean age at death 64.7 years; median disease duration 6.5 years, range 2.2 to 15.6 years). The morphologic type, topography, and frequencies of neuronal inclusions, including globular cytoplasmic (Lewy body-like) neuronal inclusions, were determined across a wide spectrum of brain regions. A correlation matrix of pathologic severity also was calculated between distinct anatomic regions of involvement (striatum, substantia nigra, olivary and pontine nuclei, hippocampus, forebrain and thalamus, anterior cingulate and neocortex, and white matter of cerebrum, cerebellum, and corpus callosum). The major finding was the identification of widespread neuronal inclusions in the majority of patients, not only in typical disease-associated regions (striatum, substantia nigra), but also within anterior cingulate cortex, amygdala, entorhinal cortex, basal forebrain and hypothalamus. Neuronal inclusion pathology appeared to follow a hierarchy of region-specific susceptibility, independent of the clinical phenotype, and the severity of pathology was duration-dependent. Neuronal inclusions also were identified in regions not previously implicated in the disease, such as within cerebellar roof nuclei. Lewy body-like inclusions in multiple system atrophy followed the stepwise anatomic progression of Lewy body-spectrum disease inclusion pathology in 25.7% of patients with multiple system atrophy, including a patient with visual hallucinations. Further, the presence of Lewy body-like inclusions in neocortex, but not hippocampal alpha-synuclein pathology, was associated with cognitive impairment (P = 0.002). However, several cases had the presence of isolated Lewy body-like inclusions at atypical sites (e.g. thalamus, deep cerebellar nuclei) that are not typical for Lewy body-spectrum disease. Finally, interregional correlations (rho ≥ 0.6) in pathologic glial and neuronal lesion burden suggest shared mechanisms of disease progression between both discrete anatomic regions (e.g. basal forebrain and hippocampus) and cell types (neuronal and glial inclusions in frontal cortex and white matter, respectively). These findings suggest that in addition to glial inclusions, neuronal pathology plays an important role in the developmental and progression of multiple system atrophy.

Original languageEnglish (US)
Pages (from-to)2293-2309
Number of pages17
JournalBrain
Volume138
Issue number8
DOIs
StatePublished - Aug 1 2015

Fingerprint

Multiple System Atrophy
Lewy Bodies
Pathology
Neuroglia
Lewy Body Disease
Cerebellar Nuclei
alpha-Synuclein
Neocortex
Gyrus Cinguli
Substantia Nigra
Thalamus
Hippocampus
Shy-Drager Syndrome
Olivary Nucleus
Cerebellar Ataxia
Entorhinal Cortex
Corpus Callosum
Hallucinations
Inclusion Bodies
Cerebrum

Keywords

  • alpha-synuclein
  • inclusion bodies
  • Lewy body-like
  • multiple system atrophy
  • neuropathology

ASJC Scopus subject areas

  • Clinical Neurology
  • Arts and Humanities (miscellaneous)

Cite this

Cykowski, M. D., Coon, E., Powell, S. Z., Jenkins, S. M., Benarroch, E. E., Low, P. A., ... Parisi, J. E. (2015). Expanding the spectrum of neuronal pathology in multiple system atrophy. Brain, 138(8), 2293-2309. https://doi.org/10.1093/brain/awv114

Expanding the spectrum of neuronal pathology in multiple system atrophy. / Cykowski, Matthew D.; Coon, Elizabeth; Powell, Suzanne Z.; Jenkins, Sarah M.; Benarroch, Eduardo E.; Low, Phillip Anson; Schmeichel, Ann M.; Parisi, Joseph E.

In: Brain, Vol. 138, No. 8, 01.08.2015, p. 2293-2309.

Research output: Contribution to journalArticle

Cykowski, MD, Coon, E, Powell, SZ, Jenkins, SM, Benarroch, EE, Low, PA, Schmeichel, AM & Parisi, JE 2015, 'Expanding the spectrum of neuronal pathology in multiple system atrophy', Brain, vol. 138, no. 8, pp. 2293-2309. https://doi.org/10.1093/brain/awv114
Cykowski MD, Coon E, Powell SZ, Jenkins SM, Benarroch EE, Low PA et al. Expanding the spectrum of neuronal pathology in multiple system atrophy. Brain. 2015 Aug 1;138(8):2293-2309. https://doi.org/10.1093/brain/awv114
Cykowski, Matthew D. ; Coon, Elizabeth ; Powell, Suzanne Z. ; Jenkins, Sarah M. ; Benarroch, Eduardo E. ; Low, Phillip Anson ; Schmeichel, Ann M. ; Parisi, Joseph E. / Expanding the spectrum of neuronal pathology in multiple system atrophy. In: Brain. 2015 ; Vol. 138, No. 8. pp. 2293-2309.
@article{d73480454fe547278a2881bafd7345d6,
title = "Expanding the spectrum of neuronal pathology in multiple system atrophy",
abstract = "Multiple system atrophy is a sporadic alpha-synucleinopathy that typically affects patients in their sixth decade of life and beyond. The defining clinical features of the disease include progressive autonomic failure, parkinsonism, and cerebellar ataxia leading to significant disability. Pathologically, multiple system atrophy is characterized by glial cytoplasmic inclusions containing filamentous alpha-synuclein. Neuronal inclusions also have been reported but remain less well defined. This study aimed to further define the spectrum of neuronal pathology in 35 patients with multiple system atrophy (20 male, 15 female; mean age at death 64.7 years; median disease duration 6.5 years, range 2.2 to 15.6 years). The morphologic type, topography, and frequencies of neuronal inclusions, including globular cytoplasmic (Lewy body-like) neuronal inclusions, were determined across a wide spectrum of brain regions. A correlation matrix of pathologic severity also was calculated between distinct anatomic regions of involvement (striatum, substantia nigra, olivary and pontine nuclei, hippocampus, forebrain and thalamus, anterior cingulate and neocortex, and white matter of cerebrum, cerebellum, and corpus callosum). The major finding was the identification of widespread neuronal inclusions in the majority of patients, not only in typical disease-associated regions (striatum, substantia nigra), but also within anterior cingulate cortex, amygdala, entorhinal cortex, basal forebrain and hypothalamus. Neuronal inclusion pathology appeared to follow a hierarchy of region-specific susceptibility, independent of the clinical phenotype, and the severity of pathology was duration-dependent. Neuronal inclusions also were identified in regions not previously implicated in the disease, such as within cerebellar roof nuclei. Lewy body-like inclusions in multiple system atrophy followed the stepwise anatomic progression of Lewy body-spectrum disease inclusion pathology in 25.7{\%} of patients with multiple system atrophy, including a patient with visual hallucinations. Further, the presence of Lewy body-like inclusions in neocortex, but not hippocampal alpha-synuclein pathology, was associated with cognitive impairment (P = 0.002). However, several cases had the presence of isolated Lewy body-like inclusions at atypical sites (e.g. thalamus, deep cerebellar nuclei) that are not typical for Lewy body-spectrum disease. Finally, interregional correlations (rho ≥ 0.6) in pathologic glial and neuronal lesion burden suggest shared mechanisms of disease progression between both discrete anatomic regions (e.g. basal forebrain and hippocampus) and cell types (neuronal and glial inclusions in frontal cortex and white matter, respectively). These findings suggest that in addition to glial inclusions, neuronal pathology plays an important role in the developmental and progression of multiple system atrophy.",
keywords = "alpha-synuclein, inclusion bodies, Lewy body-like, multiple system atrophy, neuropathology",
author = "Cykowski, {Matthew D.} and Elizabeth Coon and Powell, {Suzanne Z.} and Jenkins, {Sarah M.} and Benarroch, {Eduardo E.} and Low, {Phillip Anson} and Schmeichel, {Ann M.} and Parisi, {Joseph E}",
year = "2015",
month = "8",
day = "1",
doi = "10.1093/brain/awv114",
language = "English (US)",
volume = "138",
pages = "2293--2309",
journal = "Brain",
issn = "0006-8950",
publisher = "Oxford University Press",
number = "8",

}

TY - JOUR

T1 - Expanding the spectrum of neuronal pathology in multiple system atrophy

AU - Cykowski, Matthew D.

AU - Coon, Elizabeth

AU - Powell, Suzanne Z.

AU - Jenkins, Sarah M.

AU - Benarroch, Eduardo E.

AU - Low, Phillip Anson

AU - Schmeichel, Ann M.

AU - Parisi, Joseph E

PY - 2015/8/1

Y1 - 2015/8/1

N2 - Multiple system atrophy is a sporadic alpha-synucleinopathy that typically affects patients in their sixth decade of life and beyond. The defining clinical features of the disease include progressive autonomic failure, parkinsonism, and cerebellar ataxia leading to significant disability. Pathologically, multiple system atrophy is characterized by glial cytoplasmic inclusions containing filamentous alpha-synuclein. Neuronal inclusions also have been reported but remain less well defined. This study aimed to further define the spectrum of neuronal pathology in 35 patients with multiple system atrophy (20 male, 15 female; mean age at death 64.7 years; median disease duration 6.5 years, range 2.2 to 15.6 years). The morphologic type, topography, and frequencies of neuronal inclusions, including globular cytoplasmic (Lewy body-like) neuronal inclusions, were determined across a wide spectrum of brain regions. A correlation matrix of pathologic severity also was calculated between distinct anatomic regions of involvement (striatum, substantia nigra, olivary and pontine nuclei, hippocampus, forebrain and thalamus, anterior cingulate and neocortex, and white matter of cerebrum, cerebellum, and corpus callosum). The major finding was the identification of widespread neuronal inclusions in the majority of patients, not only in typical disease-associated regions (striatum, substantia nigra), but also within anterior cingulate cortex, amygdala, entorhinal cortex, basal forebrain and hypothalamus. Neuronal inclusion pathology appeared to follow a hierarchy of region-specific susceptibility, independent of the clinical phenotype, and the severity of pathology was duration-dependent. Neuronal inclusions also were identified in regions not previously implicated in the disease, such as within cerebellar roof nuclei. Lewy body-like inclusions in multiple system atrophy followed the stepwise anatomic progression of Lewy body-spectrum disease inclusion pathology in 25.7% of patients with multiple system atrophy, including a patient with visual hallucinations. Further, the presence of Lewy body-like inclusions in neocortex, but not hippocampal alpha-synuclein pathology, was associated with cognitive impairment (P = 0.002). However, several cases had the presence of isolated Lewy body-like inclusions at atypical sites (e.g. thalamus, deep cerebellar nuclei) that are not typical for Lewy body-spectrum disease. Finally, interregional correlations (rho ≥ 0.6) in pathologic glial and neuronal lesion burden suggest shared mechanisms of disease progression between both discrete anatomic regions (e.g. basal forebrain and hippocampus) and cell types (neuronal and glial inclusions in frontal cortex and white matter, respectively). These findings suggest that in addition to glial inclusions, neuronal pathology plays an important role in the developmental and progression of multiple system atrophy.

AB - Multiple system atrophy is a sporadic alpha-synucleinopathy that typically affects patients in their sixth decade of life and beyond. The defining clinical features of the disease include progressive autonomic failure, parkinsonism, and cerebellar ataxia leading to significant disability. Pathologically, multiple system atrophy is characterized by glial cytoplasmic inclusions containing filamentous alpha-synuclein. Neuronal inclusions also have been reported but remain less well defined. This study aimed to further define the spectrum of neuronal pathology in 35 patients with multiple system atrophy (20 male, 15 female; mean age at death 64.7 years; median disease duration 6.5 years, range 2.2 to 15.6 years). The morphologic type, topography, and frequencies of neuronal inclusions, including globular cytoplasmic (Lewy body-like) neuronal inclusions, were determined across a wide spectrum of brain regions. A correlation matrix of pathologic severity also was calculated between distinct anatomic regions of involvement (striatum, substantia nigra, olivary and pontine nuclei, hippocampus, forebrain and thalamus, anterior cingulate and neocortex, and white matter of cerebrum, cerebellum, and corpus callosum). The major finding was the identification of widespread neuronal inclusions in the majority of patients, not only in typical disease-associated regions (striatum, substantia nigra), but also within anterior cingulate cortex, amygdala, entorhinal cortex, basal forebrain and hypothalamus. Neuronal inclusion pathology appeared to follow a hierarchy of region-specific susceptibility, independent of the clinical phenotype, and the severity of pathology was duration-dependent. Neuronal inclusions also were identified in regions not previously implicated in the disease, such as within cerebellar roof nuclei. Lewy body-like inclusions in multiple system atrophy followed the stepwise anatomic progression of Lewy body-spectrum disease inclusion pathology in 25.7% of patients with multiple system atrophy, including a patient with visual hallucinations. Further, the presence of Lewy body-like inclusions in neocortex, but not hippocampal alpha-synuclein pathology, was associated with cognitive impairment (P = 0.002). However, several cases had the presence of isolated Lewy body-like inclusions at atypical sites (e.g. thalamus, deep cerebellar nuclei) that are not typical for Lewy body-spectrum disease. Finally, interregional correlations (rho ≥ 0.6) in pathologic glial and neuronal lesion burden suggest shared mechanisms of disease progression between both discrete anatomic regions (e.g. basal forebrain and hippocampus) and cell types (neuronal and glial inclusions in frontal cortex and white matter, respectively). These findings suggest that in addition to glial inclusions, neuronal pathology plays an important role in the developmental and progression of multiple system atrophy.

KW - alpha-synuclein

KW - inclusion bodies

KW - Lewy body-like

KW - multiple system atrophy

KW - neuropathology

UR - http://www.scopus.com/inward/record.url?scp=84940062763&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84940062763&partnerID=8YFLogxK

U2 - 10.1093/brain/awv114

DO - 10.1093/brain/awv114

M3 - Article

C2 - 25981961

AN - SCOPUS:84940062763

VL - 138

SP - 2293

EP - 2309

JO - Brain

JF - Brain

SN - 0006-8950

IS - 8

ER -